Sign in

CIK 0001583648

  • Non-accelerated filer
  • Smaller reporting company

PALVELLA THERAPEUTICS, INC.

Sign in to watch
Ticker
PVLA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
NV
Entity type
Operating
EIN
300784346
Phone
+1 484-253-1461
Business address
353 W. LANCASTER AVENUE, SUITE 200, WAYNE, PA, 19087
Former names
PIERIS PHARMACEUTICALS, INC., Marika Inc.
  1. 4 Derivatives Options or other derivatives
  2. 3 Insider Initial Statement of Ownership
  3. 4 Open-market buy Director bought 445 shares at $112.30 ($49,974)
  4. 4 Planned sale Chief Operating Officer sold 4,302 shares at an average $117.99 ($507,611)
  5. 4 Open-market buy Director bought 4,000 shares at $125.00 ($500,000)
  6. 4 Open-market buy Director bought 2,400 shares at $125.00 ($300,000)
  7. 4 Planned sale Chief Operating Officer sold 4,302 shares at an average $79.40 ($341,564)
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Planned sale Chief Operating Officer sold 4,302 shares at an average $97.63 ($419,983)
  14. 4 Planned sale Chief Operating Officer sold 4,302 shares at $96.47 ($415,023)
  15. 4 Planned sale Chief Operating Officer sold 4,302 shares at an average $86.23 ($370,965)
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 2 of 13 · 252 filings